Home » News » One Health debate

One Health debate

On Thursday, 28 February 2019, the ‘One Health’ debate will take place in The Hague. This debate is the conclusion of the Castellum research programme: a public-private partnership aimed at developing vaccines against zoonoses.

The Castellum programme focused on research into new vaccines for animals to prevent the introduction and spread of zoonoses. The goal of the public-private partnership was to make at least one vaccine available for the market, and this goal was achieved. The project has resulted in a new vaccine against Rift Valley fever virus (RVFV). Wageningen Bioveterinary Research (WBVR) has developed and tested the vaccine for safety and efficacy at its laboratory and animal facilities, where it is possible to work safely with zoonotic infectious diseases.

New innovation program

In 2019, the Netherlands Centre for One Health (NCOH) is launching a new Innovation Programme that is funded by the Top Sector Lifesciences and Health. The new programme is also based on a public-private partnership in the field of One Health. The One Health debate on 28 February 2019 will focus on scientific, organisational and administrative insights that emerged from Castellum programme. Relevant themes for the new Innovation Programme will also be discussed. Learn more about Castellum.

More News

One Health applications for prophylactic vaccines and preventive strategies – A joint call by Netherlands Centre for One Health and Top Sector Life Sciences & Health

The Netherlands Centre for One Health (NCOH) was allocated a budget of two million euro Public-Private Partnership (PPP) Allowance to organise and realise their first PPP call. This call involves strategic partnerships under the Knowledge and Innovation Agenda of Top Sector Life Sciences & Health (LSH): One Health call.

More

Antimicrobial resistance remains fairly stable in the Netherlands

The number of bacteria that are resistant to antibiotics is increasing globally. In the Netherlands this number remains fairly stable and is lower than in many other countries. Nevertheless, there is still cause for concern and caution. This is evident from the annual report NethMap/MARAN 2019 in which various organisations jointly present data on antibiotic... More

We’ve come a long way, thanks to a unique partnership!

A malaria vaccine, based on genetically-manipulated malaria parasites. That is the goal of Meta Roestenberg (LUMC) and Robert Sauerwein (Radboudumc). More than ten years of collaboration is nearing completion. But the vaccine could be even better…

More

The new NCOH magazine is out – edition #2 – 2019

The second edition of the NCOH Magazine has been published at the Annual Scientific Meeting at Radboudumc 17 may. Here is your chance to look at the digital version.

More